FilingIndex
10-KThe Record

Ultragenyx Pharmaceutical Inc. files 10-K

Filed Feb 21, 2024 · 2y ago · Accession 0000950170-24-017879

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
RARE
CIK
1515673
Form type
10-K
Filing date
Feb 21, 2024
Report date
Dec 31, 2023
Document
rare-20231231.htm
Size
16.6 MB